期刊文献+

血浆低密度脂蛋白水平与脑出血患者血肿增大和转归的相关性:回顾性队列研究 被引量:5

Correlation between plasma low-density fipoprotein levd and hematoma enlargement and outcome in patients with intracerebral hemonhage: A retrospective cohort study
原文传递
导出
摘要 目的 探讨血浆低密度脂蛋白(low-density lipoprotein,LDL)水平与脑出血早期血肿增大以及3个月时临床转归和死亡的关系.方法 纳入原发性脑出血患者316例,记录其一般资料,在起病6h内及24 h行CT扫描,同时检测血脂、血糖、血压以及美国国立卫生研究院卒中量表(National Institutes of Health Stroke Scale,NIHSS)评分.随访3个月,记录其改良Rankin量表(modified RankinScale, mRS)评分及死亡例数.结果 血浆LDL水平降低[优势比(odds ratio,OR)0.323,95%可信区间(confidence interval,CL)0.128~0.819;P=0.017]和收缩压增高(OR l.015,95% CI 1.000~1.029;P =0.043)与脑出血早期血肿增大独立相关.血浆LDL水平降低(OR 0.253,95%CI 0.102~0.629;P=0.003)和血糖水平增高(OR 1.458,95% CI 1.257~1.693;P<0.001)是发病3个月时的临床转归不良的独立因素.血浆LDL水平降低(OR 0.211,95% CI 0.075~0.597;P=0.003)、血糖水平增高(OR 1.406,95% CI 1.212~1.632;P=0.001)和收缩压增高(OR 1.026,95% CI 1.009~1.043;P=0.002)是3个月内死亡的独立危险因素.受试者工作特征曲线显示,LDL水平<2.58 mmol/L是血肿增大的独立预测因素(敏感性71.79%,特异性64.71%,阳性预测值40.00%,阴性预测值87.50%).结论 血浆LDL水平降低是原发性脑出血患者早期血肿增大、3个月时转归不良和死亡的独立预测因素. Objective To investigate the relationship between plasma low-density lipoprotein (LDL) levels and hematoma enlargement of early intracerebral hemorrhage,outcome at 3 months and death.Methods A total of 316 patients with primary intracerebral hemorrhage were included in the study.Their general information was documented.The patients underwent CT scans at 6 and 24 hours after onset.The lipids,blood glucose,blood pressure,and the National Institutes of Health Stroke Scale (NIHSS) scores were detected at the same time.The patients were followed up for 3 months and their modified Rankin scale (mRS) scores and the number of death were recorded.Results The decreased plasma LDL level (odds ratio [OR] 0.323,95% confidence interval [CI] 0.128 - 0.819; P =0.017) and the increased systolic pressure (OR 1.015,95% CI 1.000 -1.029; P =0.043) were independently associated with the early hematoma enlargement.The decreased plasma LDL level (OR 0.253,95% CI 0.102-0.629; P=0.003) and the increased blood glucose (OR 1.458,95% CI 1.257 - 1.693; P 〈 0.001 ) were the independent risk factors for poor outcome at 3 months after onset.The decreased plasma LDL level (OR 0.211,95% CI 0.075 - 0.597; P =0.003),the increased bloot glucose level (OR 1.406,95% CI 1.212 - 1.632; P =0.001) and the increased blood glucose level (OR 1.026,95% CI 1.009 - 1.043; P =0.002) were the independent risk factors for death within 3 months.Receiver operating characteristic curves showed that the LDL level 〈 2.58 mmol/L was an independent predictor for hematoma enlargement (sensitivity 71.79%,specificity 64.71%,positive predictive value 40.00%,and negative predictive value 87.50% ).Conclusion The decreased plasma LDL level was the independent predictor for early hematoma enlargement,poor outcome and death at 3 months in patients with primary intracerebral hemorrhage.
作者 邹蓉 赵合庆
出处 《国际脑血管病杂志》 北大核心 2012年第4期241-246,共6页 International Journal of Cerebrovascular Diseases
关键词 脑出血 胆固醇 LDL 体层摄影 X线计算机 危险因素 时间因素 预后 Cerebral Hemorrhage Cholesterol, LDL Tomography, X-Ray Computed Risk Factors Time Factors Prognosis
  • 相关文献

参考文献36

  • 1Elliott J,Smith M. The acute management of intracerebral hemorrhage:a clinical review[J].Anesthesia and Analgesia,2010.1419-1427.doi:10.1213/ANE.0b013e3181d568c8.
  • 2Brown DL,Morgenstern LB. Stopping the bleeding in intracerebral hemorrhage[J].New England Journal of Medicine,2005.828-830.
  • 3Tuhrim S. Intracerdral hemorrhageimproving outcome by reducing volume[J].New England Journal of Medicine,2008,(20):2174-2176.doi:10.1056/NEJMe0801856.
  • 4Brott T,Broderick J,Kothari R. Early hemorrhage growth in patients with intracerebral hemorrhage[J].Stroke,1997.1-5.doi:10.1161/01.STR.28.1.1.
  • 5Davis SM,Broderick J,Hennerici M. Recombinant Activated Factor Ⅶ Intracerbraral Hemorrhage Trial Investigators.Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage[J].Neurology,2006,(8):1175-1181.doi:10.1212/01.wnl.0000208408.98482.99.
  • 6Anderson CS,Huang Y,Wang JG. INTERACT Investigators.Intersive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT):a randomised pilot trial[J].Lancet Neurology,2008,(5):391-399.doi:10.1016/S1474-4422(08)70069-3.
  • 7Kazui S,Naritomi H,Yamamoto H. Enlargement of spontaneous intracerebral hemorrhage.Incidence and time course[J].Stroke,1996.1783-1787.
  • 8Kazui S,Minematsu K,Yamamoto H. Predisposing factors to enlargement of spontaneous intracerebral hematoma[J].Stroke,1997.2370-2375.
  • 9Rodriguez-Luna D,Rubiera M,Ribo M. Ultraerly hematoma growth predicts poor outcome after acute intracerebral hemorrhage[J].Neurology,2011.1599-1604.doi:10.1212/WNL.0b013e3182343387.
  • 10Leira R,Dávalos A,Silva Y. Stroke Project,Cerebrovascular Diseases Group of the Spanish Neurological Society.Early neurologic deterioration in intracerebral hemorrhage:predictors and associated factors[J].Neurology,2004.461-467.doi:10.1212/01.WNL.0000133204.81153.AC.

同被引文献39

  • 1李介华,李伟明,徐国祥,冯建容,徐辉.脑出血后不同时间脑脊液中可溶性白细胞介素6受体的变化(英文)[J].中国临床康复,2004,8(34):7850-7852. 被引量:4
  • 2周春蕾,范乐明,陈秀英,王南,陈琪.M-CSF和STAUROSPORINE促进小鼠腹腔巨噬细胞巨涎蛋白摄取OX-LDL[J].中国病理生理杂志,2005,21(12):2447-2451. 被引量:1
  • 3陈灏珠.内科学[M].北京:人民卫生出版社,2004:273.
  • 4David RL, Malta R, Marc R, et al. Serum Low - Densitylipoprotein cholesterol level predicts hematoma growth and clini - cal outcome after acute intraeerebral hemorrhage[ J ]. Stroke,2011,42 ( 9 ) :2447 - 2452.
  • 5Cuadrado - Godia E, Jimenez - Conde J, Ois A,et al. Sex differences in the prognostic value of the lipid profile after the first ischemic stroke[ J]. J Neu - rol,2009,25 (6) :989 -995.
  • 6Noda H,Iso H, Iric F, et al, Low- density lipoprotein cholesterol eoneentrions and desth due to intraparenehymal hemorrhage: the Ibaraki prefectural health study [ J ]. Circulation, 2009,119 : 2136 - 2145.
  • 7Lee JH, Park SH, Yang DH, et al. Threshold level oflow- density lipoprotein eholesterol for the short - term benefit ofstatin therapy in the acute phase of myocardial infarction [ J ]. ClinCardiol, 2012,35 (4) :211 -218.
  • 8Huang D, Pirskanen R, Hjelmstrom P, et al. Polymorphisms in IL - 1 beta and IL - lreceptor antagonist genes are associated with myasthe- nia gravis[ J]. J Neuroimmunol, 1998,81 (1/2) :76 -81.
  • 9Dinarello CA. Inierleukin - 1 [ J ]. Cytokine Growth Factor ReV, 1997,8(4) :253 -265.
  • 10Masada T, Hua Y, Xi G, et al. Attenuation ofintracerebral hemor- rhage eeptor antagonist[J]. Neurosurg,2001,95(4) :680.

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部